You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 290 No. 1, July 2, 2003 TABLE OF CONTENTS
  JAMA
  •  Online Features
  Letters
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on Web of Science (1)
 •Contact me when this article is cited
 Related Content
 •Related articles
 •Similar articles in JAMA
 Topic Collections
 •Cardiovascular System
 •Arrhythmias
 •Congestive Heart Failure/ Cardiomyopathy
 •Alert me on articles by topic
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Cardiac Resynchronization for Progressive Heart Failure

Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings.

To the Editor: In their meta-analysis, Dr Bradley and colleagues1 concluded that cardiac resynchronization reduces mortality from progressive heart failure in patients with symptomatic left ventricular dysfunction. We have several concerns, however, about their representation and interpretation of current data.

First, the review is incomplete because it failed to include at least 1 published randomized trial,2 in which no deaths occurred; excluded another3 without explanation; and only partially reported data in the public domain for a third.4

All published studies have randomized patients only after they had survived successful device implantation. These trials are blinded, proof-of-concept studies to assess whether cardiac resynchronization could improve symptoms, ventricular function, and exercise capacity. They were not, however, designed to determine the effects of cardiac resynchronization on morbidity and mortality.

Recently the Comparison of Medical Therapy, Pacing and Defibrillation in Chronic Heart Failure study comparing optimal medical therapy with cardiac resynchronization alone or cardiac . . . [Full Text of this Article]



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?

RELATED ARTICLES

Cardiac Resynchronization for Progressive Heart Failure—Reply
David J. Bradley, Steven N. Goodman, and Neil R. Powe
JAMA. 2003;290(1):37-38.
EXTRACT | FULL TEXT  

Cardiac Resynchronization and Death From Progressive Heart Failure: A Meta-analysis of Randomized Controlled Trials
David J. Bradley, Elizabeth A. Bradley, Kenneth L. Baughman, Ronald D. Berger, Hugh Calkins, Steven N. Goodman, David A. Kass, and Neil R. Powe
JAMA. 2003;289(6):730-740.
ABSTRACT | FULL TEXT  


THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Baseline characteristics of patients recruited into the CARE-HF study
Cleland et al.
Eur J Heart Fail 2005;7:205-214.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 2003 American Medical Association. All Rights Reserved.